Aurora Cannabis Inc. ACB
Set alert
At close · Oct 30
After hours · Oct 30, 6:37 PM ET
- YTD
- -3.79%
- 1 year
- -15.59%
- Open
- 4.03
- Prev close
- 4.08
- Mkt cap
- 257.04M
- Vol
- 807.14K
- Avg vol
- 1.26M
- EPS
- -0.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.99
- High
- 4.09
- Forward P/E
- -38.82
- Beta
- 2.70
- Short ratio
- 3.61
- Inst. own
- 13.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 4.88
- 200-d avg
- 5.62
- 1y target
- 0.00
5D chart
Signals (76)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:40 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:40 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:10 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 10:25 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:45 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 2:30 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:35 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:35 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:35 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 1:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:20 AM | 4 days ago |
| RSI: Oversold | Oct 28, 11:20 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:10 AM | 4 days ago |
| RSI: Oversold | Oct 28, 10:55 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 27, 3:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 3:00 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:50 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:35 PM | 5 days ago |
| RSI: Overbought | Oct 27, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:35 PM | 5 days ago |
| RSI: Overbought | Oct 27, 12:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:00 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:45 AM | 5 days ago |
| RSI: Overbought | Oct 27, 11:40 AM | 5 days ago |
| RSI: Overbought | Oct 27, 10:30 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:15 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:55 PM | 6 days ago |
News
3 days ago businesswire.com
Aurora Cannabis to Host Second Quarter 2027 Investor Conference Call
EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it will…
5 days ago zacks.com
ACB's Q2 Earnings on Deck: International Medical Cannabis in Focus
Aurora Cannabis heads into Q2 earnings with revenues expected to fall 20.1%, as market exits and reimbursement cuts weigh on results while international medical cannabis markets offer support.
-
6 days ago benzinga.com
Alberta Securities Commission Dismisses Curaleaf Holdings's Application To Halt Aurora Cannabis' February At-The-Market Program
Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today shared that the application made by Curaleaf Holdings, Inc.
6 days ago prnewswire.com
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program
NASDAQ | TSX: ACB Alberta Securities Commission dismisses Curaleaf's application concerning Aurora's ATM program. Curaleaf's unsuccessful application before the Alberta Securities Commission confirms…
1 week ago marketbeat.com
Aurora Rejects Curaleaf's Higher Bid, But the Takeover Fight Isn't Over
Curaleaf TodayCURLFCuraleaf$7.80 +0.17 (+2.26%) As of 02:38 PM Eastern52-Week Range$5.40▼$15.15Price Target$6.00Add to WatchlistCuraleaf Holdings, Inc. OTCMKTS: CURLF is aggressively maneuvering to…
1 week ago benzinga.com
Curaleaf Demands Engagement From Aurora Amid Fierce Acquisition Dispute
Curaleaf condemns Aurora Cannabis for rejecting its enhanced proposal, accusing the board of obstructing engagement and fair value.
-
1 week ago benzinga.com
Curaleaf Cites Aurora Board's Fiduciary Duty Regarding Previously Recommended Shareholder Rejection Of Curaleaf's Enhanced Proposal
Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today responded to Aurora Cannabis Inc.'s
-
2 weeks ago benzinga.com
Aurora Cannabis' Board Recommends Shareholders Reject Offer By Curaleaf Holdings
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX:ACB) (NASDAQ:ACB), the Canadian-based leading global medical cannabis company, today reconfirms that the Board of Directors (the "Board"), on
2 weeks ago prnewswire.com
Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
NASDAQ | TSX: ACB Revised Hostile Bid continues to significantly undervalue Aurora; fails to address concerns previously raised by the Board. Aurora's Special Committee is actively exploring…
2 weeks ago fool.com
Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even Higher
Curaleaf recently raised its offer for Aurora Cannabis to $5. Aurora is reviewing the bid and will make a recommendation to shareholders on what to do.
2 weeks ago defenseworld.net
Comparing Aurora Cannabis (NASDAQ:ACB) & BeOne Medicines (NASDAQ:ONC)
BeOne Medicines (NASDAQ: ONC - Get Free Report) and Aurora Cannabis (NASDAQ: ACB - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two…
3 weeks ago 247wallst.com
Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease
A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the segment that built the company's following moved the wrong way. Tilray Brands shares are at $3.
-
3 weeks ago benzinga.com
Aurora Cannabis Completes Major Expansion Of Its Facility In Leuna, Germany
Multi-million-dollar investment results in increased domestic production capacity in Germany, more than doubling expected annual flower output.Enhanced facility adopts Aurora's proven cultivation…
3 weeks ago prnewswire.com
Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
NASDAQ | TSX: ACB Multi-million-dollar investment results in increased domestic production capacity in Germany, more than doubling expected annual flower output. Enhanced facility adopts Aurora's…
-
3 weeks ago benzinga.com
Aurora Cannabis Shareholders Urged For No Action Against Curaleaf's Hostile Acquisition Offer
Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings,…
3 weeks ago prnewswire.com
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway
Aurora's Special Committee will commence a thorough and independent review of the revised Hostile Bid and the Board will provide a formal recommendation to shareholders once the review is complete.…
3 weeks ago marketbeat.com
Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
The multi-year cannabis sector bear market is starting to give way to a calculated wave of industry consolidation. Behind the urge to merge is a significant shift in U.S. federal regulatory policy,…
3 weeks ago prnewswire.com
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
NASDAQ | TSX: ACB Curaleaf has yet to file a Notice of Variation and Change to revise its offer. Once filed, the Special Committee will complete a thorough and comprehensive review prior to issuing a…
3 weeks ago defenseworld.net
Aurora Cannabis (TSE:ACB) Shares Up 15.6% – Still a Buy?
Shares of Aurora Cannabis Inc. (TSE: ACB - Get Free Report) rose 15.6% on Monday. The stock traded as high as C$6.51 and last traded at C$6.45. Approximately 914,036 shares traded hands during…
3 weeks ago defenseworld.net
Aurora Cannabis Sees Unusually High Options Volume (NASDAQ:ACB)
Aurora Cannabis Inc. (NASDAQ: ACB - Get Free Report) was the recipient of some unusual options trading activity on Monday. Traders acquired 2,710 call options on the stock. This is an increase of…
3 weeks ago proactiveinvestors.com
Curaleaf raises Aurora Cannabis offer by 25%
Curaleaf Hldgs Inc. (OTCQX:CURLF), the Connecticut-based cannabis company, has raised its offer for Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB), a Canadian cannabis producer, by 25% to a total implied…
3 weeks ago defenseworld.net
Comparing ProPhase Labs (NASDAQ:PRPH) and Aurora Cannabis (NASDAQ:ACB)
ProPhase Labs (NASDAQ: PRPH - Get Free Report) and Aurora Cannabis (NASDAQ: ACB - Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two…
-
1 month ago benzinga.com
'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
https://www.marijuanamoment.net/dea-judge-pauses-marijuana-rescheduling-hearing-as-opponents-highlight-government-report-detailing-gaps-in-federal-processes/
1 month ago fool.com
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.
Curaleaf presented an unsolicited offer to buy Aurora Cannabis for $4 per share. Aurora rejected the offer, saying it didn't fully value Aurora's business.
1 month ago prnewswire.com
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
NASDAQ | TSX: ACB Aurora has filed an application with the Alberta Securities Commission for an order requiring Curaleaf to comply with securities laws. Aurora intends to demonstrate that Curaleaf's…
-
1 month ago benzinga.com
Aurora Cannabis Re-Affirms FY27 Q2 Guidance For Sequential Growth In Quarterly Net Revenue And Adjusted EBITDA
Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA1Following the receipt of EU-GMP certification in July, Safari Flower Company is expected to contribute…
1 month ago prnewswire.com
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
NASDAQ| TSX: ACB Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA 1 Following the receipt of EU-GMP certification in July, Safari Flower Company is…
1 month ago marketbeat.com
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
Cross-border consolidation in the cannabis industry has moved from executive speculation into aggressive dealmaking. As regulatory hurdles begin to clear across North America and Europe, operators…
-
1 month ago benzinga.com
Curaleaf Pens Letter To Aurora Cannabis Shareholders Urging Acceptance Of Its Takeover Offer
In a letter released today, Chairman and CEO Boris Jordan encouraged Aurora shareholders to review the facts and carefully consider the alternatives available to them.Curaleaf Holdings, Inc.…
2 months ago benzinga.com
Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid
Aurora Cannabis urges shareholders to reject Curaleaf's unsolicited hostile bid, calling the offer undervaluation with serious risks.
-
2 months ago benzinga.com
Aurora Cannabis Urged Shareholders To Reject A Merger Bid From Curaleaf, Warning That The Hostile Bid Would Put Aurora Shareholders' Value And Future Upside At Risk
Curaleaf's hostile and opportunistic bid significantly undervalues Aurora, and aims to capture Aurora's assets at a discountAurora is debt free and holds $149 million in cash1, Curaleaf carries over…
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release,…
2 months ago benzinga.com
Curaleaf Goes Public with Premium Acquisition Proposal for Aurora Cannabis
Curaleaf proposes to acquire Aurora Cannabis for $4 per share, offering a 45% premium to expand global operations.
-
2 months ago benzinga.com
Curaleaf Proposes $4.00/Share Offer For Aurora Cannabis
Proposed Offer reflects a 45% premium to Aurora's 30-day VWAP and a 110% premium to Aurora's 30-day VWAP excluding balance sheet cash Provides Aurora shareholders with the opportunity to become…
-
2 months ago benzinga.com
Aurora Cannabis Q1 EPS $(0.05) Beats $(0.13) Estimate, Sales $48.798M Miss $50.510M Estimate
Aurora Cannabis (NASDAQ:ACB) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. This is a 73.68 percent increase over losses of…
-
4 months ago benzinga.com
Full Transcript: Aurora Cannabis Q4 2026 Earnings Call
Full Transcript: Aurora Cannabis Q4 2026 Earnings Call
-
4 months ago benzinga.com
Aurora Cannabis Q4 EPS $(0.35) Misses $(0.07) Estimate, Sales $61.842M Beat $55.290M Estimate
Aurora Cannabis (NASDAQ:ACB) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.07) by 400 percent. This is a 45.83 percent decrease over losses of…
-
4 months ago benzinga.com
'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amending-broad-ban-thats-set-to-take-effect-later-this-year/
-
5 months ago benzinga.com
"Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment
https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
-
5 months ago benzinga.com
Aurora Cannabis Receives Plant Breeders' Rights In Canada For Two Proprietary Cannabis Cultivars
This certification gives Aurora the exclusive rights to grow, propagate, and sell finished products produced from these varieties.The two protected cultivars, SOT20R07-007 (known as Farm Gas™) and…
-
6 months ago benzinga.com
Aurora Cannabis Launches Newly Expanded Lineup, Including Dried Flower, Pre‑Rolls And Pastilles
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, is significantly expanding its global medical cannabis portfolio, with new product launches…
-
6 months ago benzinga.com
'Trump Reclassifies State-Licensed Medical Marijuana As A Less-Dangerous Drug In A Historic Shift' - AP News
https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3aae122b1a91f8e4b6c690268
-
6 months ago benzinga.com
'Trump Administration Is Expected To Move To Reclassify Marijuana As Soon As Wednesday' - Axios
https://www.axios.com/2026/04/22/trump-marijuana-rule-change
-
7 months ago benzinga.com
'White House Schedules Meeting On Cannabis Products Enforcement Policy For Next Week'- Marijuana Moment
https://www.marijuanamoment.net/white-house-schedules-meeting-on-cannabis-products-enforcement-policy-for-next-week/
-
7 months ago benzinga.com
'Marijuana Businesses Could List On US Stock Exchanges Like Nasdaq And NYSE Under New Bipartisan Congressional Bill' - Marijuana Moment
https://www.marijuanamoment.net/marijuana-businesses-could-list-on-us-stock-exchanges-like-nasdaq-and-nyse-under-new-bipartisan-congressional-bill/
-
7 months ago benzinga.com
'Medicare CBD Pilot Will Allow Some THC in Products'- Cannabis Wire
https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_read=1773920530418
-
8 months ago benzinga.com
'Federal Agency Finalized Rule For CBD Medicare Coverage Pilot Program Weeks Ago, Key Hemp Stakeholder Says'- Marijuana Moment
https://www.marijuanamoment.net/federal-agency-finalized-rule-for-cbd-medicare-coverage-pilot-program-weeks-ago-key-hemp-stakeholder-says/
-
8 months ago benzinga.com
'GOP Congressman Isn't Sure Marijuana Rescheduling Is A DOJ 'Priority,' But Remains Optimistic About Progress Under Trump' - Marijuana Moment
https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-but-remains-optimistic-about-progress-under-trump/
-
9 months ago benzinga.com
Earnings Scheduled For February 4, 2026
Earnings Scheduled For February 4, 2026